Citigroup’s Silo Pharma SILO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6 Buy
+1
New +$6 ﹤0.01% 5614
2026
Q1
Sell
-230
Closed -$1.19K 6356
2025
Q4
$1.17K Buy
+230
New +$1.7K ﹤0.01% 5532
2025
Q3
Sell
-724
Closed -$6.85K 6298
2025
Q2
$6.85K Buy
724
+622
+610% +$7.13K ﹤0.01% 5241
2025
Q1
$1.79K Sell
102
-77
-43% -$1.72K ﹤0.01% 5346
2024
Q4
$2.4K Buy
+179
New +$2.77K ﹤0.01% 5539

Other funds holding SILO

Citigroup's SILO Position: Q2 2026 in Review

Citigroup opened a new position in Silo Pharma (SILO) in Q2 2026: 1 share worth $6. The stake represents ﹤0.01% of the portfolio and ranks #5614 among its holdings. This is a return to the name: Citigroup previously reported a position in SILO as recently as Q4 2025.

Citigroup first reported a position in SILO in Q4 2024 and has held it in 5 quarters since. The position peaked at $6.85K in Q2 2025. 9 funds tracked by Wall St. Rank hold SILO as of Q2 2026.

  • Citigroup held 1 share of Silo Pharma worth $6 as of Q2 2026.
  • Silo Pharma was a new Citigroup position in Q2 2026.
  • Silo Pharma made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5614 holding.
  • Citigroup first reported a position in Silo Pharma in Q4 2024 and has held it in 5 quarters since.
  • Citigroup's Silo Pharma position peaked at $6.85K in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Silo Pharma as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.